Best Heal Care Companies To Buy Right Now

With shares of Lowe�� Companies Inc. (NYSE:LOW) trading at around $42.97, is LOW an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

C = Catalyst for the Stock�� Movement

If you live near a Lowe�� then there�� a good chance that you also live near a Home Depot. If that�� the case, then there’s an important question that must be asked. When it rains, does it only rain over Lowe��? If that�� the case, then�your town or city has�an atmospheric phenomenon. However, if this doesn�� happen where you live, then it sounds like Lowe�� is making excuses. There�� no other way to spin it, considering Lowe�� blamed the weather for a poor quarter while The Home Depot (NYSE:HD) shrugged off the weather as though it was a mosquito sitting on its shoulder at a Sunday night barbecue.

Home Depot is winning this battle in strategic locations and merchandising, and it�� now ahead in cost management. Some people might be wondering how Home Depot consistently outperforms Lowe�� when Lowe�� is widely known for offering such better service. A lot of it has to do with contracting. Approximately 35 percent of Home Depot sales are from contractors. Only 25 percent of Lowe�� sales are from contractors. Therefore, retail shoppers are more important to Lowe�� and must be treated with more respect. Lowe�� is attempting to improve retail sales by increasing effective worker hours.

Top Transportation Stocks To Watch Right Now: Winmark Corporation(WINA)

Winmark Corporation operates as a franchisor of four retail store concepts that buy, sell, trade, and consign merchandise. The company franchises retail stores under the ?Plato?s Closet? name that sell and buy used clothing and accessories geared toward the teenage and young adult market; and under the ?Play It Again Sports? name, which sell, buy, trade, and consign used and new sporting goods, equipment, and accessories for various athletic activities, including hockey, wheeled sports, fitness, ski/snowboard, golf, and baseball/softball. It engages in franchising ?Once Upon A Child? branded retail stores that sell and buy used and new children?s clothing, toys, furniture, equipment, and accessories; and ?Music Go Round? branded retail stores that sell, buy, trade, and consign used and new musical instruments, speakers, amplifiers, music-related electronics, and related accessories for parents of children who play musical instruments, as well as for professional and amateur musicians. In addition, the company operates a middle-market equipment leasing business focusing on technology-based assets to serve large and medium-sized businesses; and a small-ticket financing business to serve small businesses. Further, it offers management services to Tomsten, Inc. As of September 24, 2011, the company had 923 franchises in operation. Winmark Corporation was founded in 1988 and is headquartered in Minneapolis, Minnesota.

Advisors' Opinion:

• [By Monica Wolfe]

  Winmark Corporation (WINA)

  Chairman and CEO John Morgan of Winmark Corporation made a notable buy on July 29. The CEO purchased 2,000 shares at approximately $68.55 per share. This transaction cost the CEO $137,100. Since his most recent buy, the price per share has increased approximately 5.56%. Morgan currently holds over 1.7 million shares of Winmark.

• [By Michael Lewis]

  One of my favorite businesses, Winmark (NASDAQ: WINA  ) , reported earnings this week. Earnings boosted 14% compared to the prior year's first quarter. Though the company continues to franchise its range of secondhand stores, the most compelling growth comes from the leasing division, which saw revenues jump by 30%. The company is underfollowed yet has been paying attractive special dividends while giving investors two-year capital appreciation of roughly 50%. As the company moves forward and pushes its leasing business to new heights, should you get in now?

Best Heal Care Companies To Buy Right Now: Weir Group PLC (WEIR)

The Weir Group PLC is engaged in engineering businesses. It operates in three segments: Minerals, Oil and Gas, and Power and Industrial. The Minerals segment provides slurry handling equipment and associated aftermarket support for abrasive high wear applications used in the mining and oil sands markets. The Oil & Gas segment provides products and service solutions to upstream, production, transportation, refining and related industries. The Power & Industrial segment designs and manufactures valves, pumps and turbines as well as providing specialist support services to the global power generation, industrial and oil and gas sectors. The Company�� subsidiaries include American Hydro Corporation, EnviroTech Pumpsystems Inc, Gema Industrigummi AB, Linatex Rubber Products Sdn Bhd and Mesa Manufacturing Inc. Advisors' Opinion:

• [By Inyoung Hwang]

  Weir Group Plc (WEIR) added 1.6 percent to 2,239 pence, the highest price in almost two months. The U.K.�� largest supplier of pressure pumps was raised to buy from hold at Berenberg Bank.

Best Heal Care Companies To Buy Right Now: Nordic American Tanker Ltd (NAT)

Nordic American Tankers Limited is an international tanker company. As of December 31, 2011, the Company owned 20 Suezmax tankers. The Company�� vessels include Nordic Harrier, Nordic Hawk, Nordic Hunter, Nordic Voyager, Nordic Freedom, Nordic Fighter, Nordic Discovery, Nordic Saturn, Nordic Jupiter, Nordic Apollo and Nordic Moon. Its vessels also include Nordic Cosmos, Nordic Sprite, Nordic Grace, Nordic Mistral, Nordic Passat, Nordic Vega, Nordic Breeze, Nordic Aurora and Nordic Zenith. In September 2011, the Company acquired the vessel, Nordic Aurora. It chartered all of its vessels in the spot market pursuant to a cooperative arrangement with Gemini Tankers LLC until November 24, 2011. In November 2011, the Orion Tankers pool was established with Orion Tankers Ltd. as pool manager and its vessels were transferred from the Gemini Tankers LLC arrangement to the Orion Tankers pool. On December 17, 2012, the Company acquired 100% interest in Scandic American Shipping Ltd. Advisors' Opinion:

• [By Robert Rapier]

  Nordic American Tanker (NYSE: NAT) is a Bermuda-based tanker company that acquires and charters double-hull tankers. Its fleet consists of 20 double-hull Suezmax tankers. Besides the factor you mention about more ships coming onto the market, NAT has underperformed — period. Shares have lost two-thirds of their value over the past five years, and the dividend has been cut multiple times.

• [By Rich Duprey]

  Nordic American Tankers (NYSE: NAT  ) has decided to pull up anchor on a $55 million Suezmax tanker it had agreed to buy in March, saying the seller wouldn't be able to deliver the ship on time.

• [By Eric Volkman]

  Nordic American Tankers (NYSE: NAT  ) is presenting a calm sea to its stockholders by keeping its upcoming dividend level with the previous payout. The company has declared a distribution of $0.16 per share of its common stock for its Q1, which its expects to hand out "on or about" May 14. It expects that the record date will be April 30.

• [By Rich Duprey]

  Shipping magnate�Nordic American Tankers (NYSE: NAT  ) announced today its second-quarter dividend of $0.16 per share, the same rate it's paid for the past two quarters after slashing the payout 47% from $0.30 per share. Even so, it marks the 64th consecutive quarterly dividend payment the tanker operator has made.

Best Heal Care Companies To Buy Right Now: Pain Therapeutics Inc (PTIE)

Pain Therapeutics, Inc., incorporated in May 1998, is a biopharmaceutical company that develops drugs. The Company has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a radio-labeled monoclonal antibody to treat metastatic melanoma. It is also working on a new treatment for patients with hemophilia. The Company�� lead drug candidate is REMOXY, which is a painkiller. It has collaboration agreement with King Pharmaceuticals, Inc. (King) develops and commercializes REMOXY and other opioid painkillers. The Company and King jointly managed a Phase III clinical program and New Drug Application (NDA) submission for REMOXY. It is also developing a pipeline of drug candidates in the area of oncology and hematology. It owns all commercial rights to its pipeline of drug candidates in oncology and hematology. As of December 31, 2010, the Company leased approximately 30,700 square feet of space in San Mateo, California and all of its operations are located in San Mateo.

REMOXY

REMOXY is a controlled-release oral capsule form of oxycodone in a highly viscous liquid formulation matrix that includes excipients. It is formulated to help address issues of abuse and misuse of time-release oxycodone tablets. REMOXY�� capsule dosage form provides therapeutic drug levels of oxycodone on a twice-daily dosing schedule, while resisting the rapid increases in plasma levels of oxycodone associated with common methods of abuse and misuse. Its formulation also resists delivery by unapproved routes of administration, such as injection, snorting or inhalation.

Metastatic Melanoma

The Company is developing a drug candidate called PTI-188 to treat metastatic melanoma, a form of skin cancer. PTI-188 is a monoclonal antibody linked to a radioisotope, intended to deliver doses of radiation lethal to melanoma tumors without harming normal tissue. In March 2010, the Company announced data from two open-label! , dose-escalating Phase I studies conducted in Israel to assess the safety, pharmacokinetics, dosimetry and anti-tumor activity of PTI-188. During the year ended December 31, 2010, the second study was completed. The technology used in this program was developed at the Albert Einstein College of Medicine (AECOM). It had licensed worldwide commercial rights to this technology from AECOM.

Hemophilia

The Company has a gene transfer program, initially developed at Stanford University, focused at correcting a genetic disorder in which patients are unable to stop bleeding. During 2010, it conducted a variety of pre-clinical studies with this technology. The Company has licensed worldwide commercial rights to the technology used in this program from Poetic Genetics, LLC (Poetic).

Other product candidates

The Company�� alliance with King includes development of three other abuse-resistant opioid product candidates: hydromorphone, hydrocodone and oxymorphone. Its abuse-resistant formulations of hydromorphone and hydrocodone have completed Phase I clinical trials. In January 2011, the Company announced that the Food and Drug Administration (FDA) had accepted its investigational IND, for abuse-resistant oxymorphone.

The Company competes with Roxane Laboratories, Purdue Pharma, King Pharmaceuticals, Inc., Abbott Laboratories, Cephalon, Endo Pharmaceuticals, Teva Pharmaceuticals, Elkins-Sinn, Watson Laboratories, Ortho-McNeil Pharmaceutical and Forest Pharmaceuticals.

Advisors' Opinion:

• [By Jessica Alling]

  Elsewhere, Pfizer is evaluating its continued partnership on an experimental oxycodone capsule, Remoxy. The drug is an extended-release formula that is targeted at reducing abuse of the painkiller. After years of setbacks and postponements for FDA approval, Pfizer is weighing its options. Its partners for the drug, Pain Therapeutics (NASDAQ: PTIE  ) and Durect, have both fallen heavily due to the news, with Pain Therapeutics falling more than 50% -- its largest decline ever.